Kbc Group Nv Cardiovascular Systems Inc Transaction History

Kbc Group Nv

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 14, 2024	SELL	$13.31 - $19.86 $10,049 - $14,994	-755 Reduced 18.54%	3,317 $66,000
Q1 2023 May 04, 2023	SELL	$13.31 - $19.86 $10,049 - $14,994	-755 Reduced 18.54%	3,317 $66,000
Q3 2022 Feb 15, 2024	BUY	$12.93 - $17.17 $52,650 - $69,916	4,072 New	4,072 $56,000
Q2 2022 Feb 14, 2024	SELL	$13.53 - $23.34 $247,842 - $427,542	-18,318 Reduced 81.81%	4,072 $58,000
Q2 2022 Jul 26, 2022	SELL	$13.53 - $23.34 $247,842 - $427,542	-18,318 Reduced 81.81%	4,072 $58,000
Q1 2022 Feb 14, 2024	BUY	$16.14 - $22.6 $204,009 - $285,664	12,640 Added 129.64%	22,390 $506,000
Q1 2022 May 06, 2022	BUY	$16.14 - $22.6 $204,009 - $285,664	12,640 Added 129.64%	22,390 $506,000
Q4 2021 Feb 14, 2024	BUY	$18.64 - $36.77 $181,740 - $358,507	9,750 New	9,750 $183,000
Q3 2021 Nov 10, 2021	BUY	$32.83 - $43.0 $320,092 - $419,250	9,750 New	9,750 $320,000
Q1 2021 Apr 26, 2021	SELL	$37.29 - $47.19 $19,539 - $24,727	-524 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$34.3 - $44.09 $17,973 - $23,103	524 New	524 $23,000

35.5K

Ticker CSII
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 41,905,900
Description
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.